Bringing the Oncology Community Together

Dr. Neumayer Discusses the POWER PIINC Trial

Leigh A. Neumayer, MD
Published Online: Wednesday, December 18, 2013
Leigh A. Neumayer, MD, professor of surgery, University of Utah School of Medicine, co-director of the multidisciplinary team treating breast cancer at Huntsman Cancer Institute, discusses the POWER PIINC trial, a study to measure the preoperative window of endocrine therapy.

Neumayer says patients with early stage breast cancer will receive 7 days of preoperative tamoxifen. After the surgery, the patients will then receive tamoxifen for 14 days in order to counteract the immunosuppressive nature of surgery. The study has enrolled 40 patients so far.

Neumayer says the trial will allow researchers to develop a better understanding of the symptoms associated with tamoxifen. These patients will be followed for 18 months in order to determine if there is a change in compliance. Neumayer believes if patients have a chance to try out tamoxifen, they might be willing to go on it later.

Related Articles
Case Study: HER2-Positive Oligometastatic Breast Cancer
In this segment, panelists explore the treatment of a 40-year-old woman with a 2 cm mass in her left breast and a 2 cm liver lesion, both of which test positive for HER2 overexpression.
Experts Debate Utility of Genomic Profiling in Daily Practice
Although the potential for next-generation sequencing of breast cancer tumors to improve treatment strategies is widely recognized, questions swirl about the optimal use of such increasingly available technologies in clinical practice for today’s patients.
AR Findings Highlight Detailed Tumor-Profiling Study
A wide-ranging analysis of more than 5500 breast cancer tumors that combined genomic and protein expression testing has identified promising targets to explore for treating patients with poor prognoses, with particularly notable findings involving androgen receptor (AR) expression
Most Popular Right Now
More Reading
External Resources

American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc
OncLive Resources

Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Specialties
Web Exclusives


About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright OncLive 2006-2014
Intellisphere, LLC. All Rights Reserved.